Jose-Luis Perez-Gracia

17PUBLICATIONS
134CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Cell physiologyMolecular targetsInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 09, 2026
Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study.

Jose Luis Perez-Gracia, Begoña Mellado, Aaron Richard Hansen

|Jan 16, 2026
Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab.

Miguel F Sanmamed, Carlos E de Andrea, David Ruiz-Guillamon

|Mar 17, 2025
A Phase I Dose Escalation and Cohort Expansion Study of CB307, a Trispecific Humabody against PSMA, CD137, and Albumin in Patients with PSMA-Positive Solid Tumors.

Johann S de Bono, Anja Williams, Ignacio Melero

|Feb 13, 2025
Association of [68Ga]Ga-PSMA-11 PET/CT Metrics with PSA Persistence Following Radical Prostatectomy in Patients with Intermediate- and High-Risk Prostate Cancer.

Juan J Rosales, Vicky Betech-Antar, Fernando Mínguez

|Nov 12, 2024
Targeting T-Cell Costimulation to the Surface of Tumor Cells.

Iñaki Eguren-Santamaría, Miguel F Sanmamed, Paula Molero-Glez

|Apr 17, 2024
Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.

Alvaro Teijeira, Saray Garasa, Maria C Ochoa

Pageof 3

Frequent Collaborators

8 joint publications

Ignacio Melero

4 joint publications

Pedro Berraondo

4 joint publications

Iñaki Eguren-Santamaria

3 joint publications

Miguel F Sanmamed